BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33524001)

  • 1. MCM7 as a marker of postsurgical progression in non-functioning pituitary adenomas.
    Hallén T; Olsson DS; Hammarstrand C; Örndal C; Engvall A; Ragnarsson O; Skoglund T; Johannsson G
    Eur J Endocrinol; 2021 Apr; 184(4):521-531. PubMed ID: 33524001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonfunctioning pituitary adenomas: association of Ki-67 and HMGA-1 labeling indices with residual tumor growth.
    Šteňo A; Bocko J; Rychlý B; Chorváth M; Celec P; Fabian M; Belan V; Šteňo J
    Acta Neurochir (Wien); 2014 Mar; 156(3):451-61; discussion 461. PubMed ID: 24452592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Minichromosome maintenance protein 7 as prognostic marker of tumor aggressiveness in pituitary adenoma patients.
    Coli A; Asa SL; Fadda G; Scannone D; Chiloiro S; De Marinis L; Lauretti L; Ranelletti FO; Lauriola L
    Eur J Endocrinol; 2016 Mar; 174(3):307-14. PubMed ID: 26620390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic Profiles Associated With Postsurgical Progression in Nonfunctioning Pituitary Adenomas.
    Hallén T; Johannsson G; Thorsell A; Olsson DS; Örndal C; Engvall A; Jacobson F; Widgren A; Bergquist J; Skoglund T
    J Clin Endocrinol Metab; 2024 May; 109(6):1485-1493. PubMed ID: 38157275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pituitary tumor transforming gene and insulin-like growth factor 1 receptor expression and immunohistochemical measurement of Ki-67 as potential prognostic markers of pituitary tumors aggressiveness.
    Sánchez-Tejada L; Sánchez-Ortiga R; Moreno-Pérez O; Montañana CF; Niveiro M; Tritos NA; Alfonso AM
    Endocrinol Nutr; 2013; 60(7):358-67. PubMed ID: 23416216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ki-67 expression for predicting progression of postoperative residual pituitary adenomas: correlations with clinical variables.
    Matsuyama J
    Neurol Med Chir (Tokyo); 2012; 52(8):563-9. PubMed ID: 22976139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pituitary tumour transforming gene (PTTG) expression correlates with the proliferative activity and recurrence status of pituitary adenomas: a clinical and immunohistochemical study.
    Filippella M; Galland F; Kujas M; Young J; Faggiano A; Lombardi G; Colao A; Meduri G; Chanson P
    Clin Endocrinol (Oxf); 2006 Oct; 65(4):536-43. PubMed ID: 16984249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth pattern and rate in residual nonfunctioning pituitary adenomas: correlations among tumor volume doubling time, patient age, and MIB-1 index.
    Tanaka Y; Hongo K; Tada T; Sakai K; Kakizawa Y; Kobayashi S
    J Neurosurg; 2003 Feb; 98(2):359-65. PubMed ID: 12593623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke's cell morphology.
    Garbicz F; Mehlich D; Rak B; Sajjad E; Maksymowicz M; Paskal W; Zieliński G; Włodarski PK
    Pituitary; 2017 Aug; 20(4):450-463. PubMed ID: 28432562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ki-67 and minichromosome maintenance-7 (MCM7) expression in canine pituitary corticotroph adenomas.
    Ishino H; Hara Y; Takekoshi S; Teshima T; Teramoto A; Osamura RY; Tagawa M
    Domest Anim Endocrinol; 2011 Nov; 41(4):207-13. PubMed ID: 21982272
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MCM4 and MCM7, potential novel proliferation markers, significantly correlated with Ki-67, Bmi1, and cyclin E expression in esophageal adenocarcinoma, squamous cell carcinoma, and precancerous lesions.
    Choy B; LaLonde A; Que J; Wu T; Zhou Z
    Hum Pathol; 2016 Nov; 57():126-135. PubMed ID: 27476776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of the World Health Organization definition of atypia on surgically treated functional and non-functional pituitary adenomas.
    Sarkar S; Philip VJ; Cherukuri SK; Chacko AG; Chacko G
    Acta Neurochir (Wien); 2017 Nov; 159(11):2179-2186. PubMed ID: 28573325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual nonfunctioning pituitary adenomas: prognostic value of MIB-1 labeling index for tumor progression.
    Widhalm G; Wolfsberger S; Preusser M; Fischer I; Woehrer A; Wunderer J; Hainfellner JA; Knosp E
    J Neurosurg; 2009 Sep; 111(3):563-71. PubMed ID: 18991501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High minichromosome maintenance protein 7 proliferation indices: a powerful predictor of progression in pancreatic neuroendocrine neoplasms without distant metastasis at the time of surgery.
    Ban X; Yan J; Yu S; Lu Z; Chang X; Jia C; Gao C; Shao H; Wu Y; Mao X; Zhang Y; Li Y; Chen J
    Hum Pathol; 2019 Mar; 85():101-111. PubMed ID: 30447299
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-functioning pituitary adenomas with positive immunoreactivity for ACTH behave more aggressively than ACTH immunonegative tumours but do not recur more frequently.
    Bradley KJ; Wass JA; Turner HE
    Clin Endocrinol (Oxf); 2003 Jan; 58(1):59-64. PubMed ID: 12519413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giant pituitary adenomas: pathologic-radiographic correlations and lack of role for p53 and MIB-1 labeling.
    Madsen H; Borges TM; Knox AJ; Michaelis KA; Xu M; Lillehei KO; Wierman ME; Kleinschmidt-DeMasters BK
    Am J Surg Pathol; 2011 Aug; 35(8):1204-13. PubMed ID: 21753697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-functioning pituitary adenomas: clinical features and immunohistochemistry].
    Ferreira JE; de Mello PA; de Magalhães AV; Botelho CH; Naves LA; Nosé V; Schmitt F
    Arq Neuropsiquiatr; 2005 Dec; 63(4):1070-8. PubMed ID: 16400431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide DNA Methylation Differences in Nonfunctioning Pituitary Adenomas With and Without Postsurgical Progression.
    Hallén T; Johannsson G; Dahlén R; Glad CAM; Örndal C; Engvall A; Carén H; Skoglund T; Olsson DS
    J Clin Endocrinol Metab; 2022 Jul; 107(8):2318-2328. PubMed ID: 35485764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression analysis of cyclins in pituitary adenomas and the normal pituitary gland.
    Turner HE; Nagy Z; Sullivan N; Esiri MM; Wass JA
    Clin Endocrinol (Oxf); 2000 Sep; 53(3):337-44. PubMed ID: 10971451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTTG and Ki-67 expression in pituitary adenomas.
    Wierzbicka-Tutka I; Sokołowski G; Bałdys-Waligórska A; Adamek D; Radwańska E; Gołkowski F
    Przegl Lek; 2016; 73(2):53-8. PubMed ID: 27197423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.